• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于眼部的聚合物的物理化学、体外和体内特性研究

Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use.

作者信息

Hartmann V, Keipert S

机构信息

Institute of Pharmacy, Humboldt-University, Berlin, Germany.

出版信息

Pharmazie. 2000 Jun;55(6):440-3.

PMID:10907252
Abstract

The influence of artificial tear fluid (AT) on ionic and nonionic ophthalmic polymer excipients was rheologically established. In usual concentrations polyvinylalcohol, polyvinylpyrrolidone, dextran, hydroxypropylmethylcellulose, hydroxyethylcellulose and methylcellulose did not show any changes. In contrast, solutions of polyacrylic acid, sodium hyaluronate (S-Hya), sodium alginate (S-Alg) and chitosan decrease the apparent viscosity in contact with AT, while gellan solution increases the viscosity and shows thixotropy. The adhesion of selected polymers (polysaccharides) on mucin was evaluated using a rheological method and resulted in the order S-Hya > Gellan > S-Alg > dextran. Miosis testing of Gellan containing pilocarpine HCl formulations in rabbits shows a possible reduction of drug concentration from 2% to 0.5% obtaining the same bioavailability.

摘要

通过流变学方法确定了人工泪液(AT)对离子型和非离子型眼科聚合物辅料的影响。在常规浓度下,聚乙烯醇、聚乙烯吡咯烷酮、右旋糖酐、羟丙基甲基纤维素、羟乙基纤维素和甲基纤维素均未显示出任何变化。相比之下,聚丙烯酸、透明质酸钠(S-Hya)、海藻酸钠(S-Alg)和壳聚糖溶液在与AT接触时会降低表观粘度,而结冷胶溶液则会增加粘度并表现出触变性。使用流变学方法评估了所选聚合物(多糖)对粘蛋白的粘附性,结果顺序为S-Hya>结冷胶>S-Alg>右旋糖酐。对含结冷胶的盐酸毛果芸香碱兔用制剂进行的缩瞳试验表明,药物浓度可能从2%降至0.5%,但生物利用度相同。

相似文献

1
Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use.用于眼部的聚合物的物理化学、体外和体内特性研究
Pharmazie. 2000 Jun;55(6):440-3.
2
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.离子敏感型原位凝胶眼用给药系统的比较。第 1 部分:理化性质考察和体外释放。
Int J Pharm. 2011 Jun 15;411(1-2):69-77. doi: 10.1016/j.ijpharm.2011.03.042. Epub 2011 Mar 29.
3
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.离子敏感型原位凝胶眼用给药系统的比较。第 2 部分:角膜前滞留和体内药效学研究。
Int J Pharm. 2011 Jun 15;411(1-2):78-85. doi: 10.1016/j.ijpharm.2011.03.043. Epub 2011 Mar 29.
4
Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.基于结冷胶和羟乙基纤维素的新型原位凝胶眼用给药系统:创新的流变学特征、体外和体内证据表明具有延长的角膜前滞留时间。
Int J Pharm. 2020 Jan 25;574:118734. doi: 10.1016/j.ijpharm.2019.118734. Epub 2019 Nov 6.
5
L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.L-肌肽:用于长效局部眼科制剂的多功能二肽缓冲剂。
J Pharm Pharmacol. 2009 Jun;61(6):733-42. doi: 10.1211/jpp/61.06.0005.
6
[Use of a novel polymer, the in-situ gelling mucoadhesive thiolated poly(aspartic acid) in ophthalmic drug delivery].[一种新型聚合物,即原位凝胶化粘膜粘附性硫醇化聚天冬氨酸在眼科药物递送中的应用]
Acta Pharm Hung. 2015;85(4):115-21.
7
Gellan gum and its methacrylated derivatives as in situ gelling mucoadhesive formulations of pilocarpine: In vitro and in vivo studies.结冷胶及其甲基丙烯酰化衍生物作为毛果芸香碱的原位凝胶型黏附制剂:体外和体内研究。
Int J Pharm. 2020 Mar 15;577:119093. doi: 10.1016/j.ijpharm.2020.119093. Epub 2020 Jan 28.
8
In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine.用于毛果芸香碱眼部给药的海藻酸盐/泊洛沙姆溶液的原位凝胶化
Biomacromolecules. 2004 Nov-Dec;5(6):2358-65. doi: 10.1021/bm0496965.
9
In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.用于盐酸毛果芸香碱缓释眼部给药的原位凝胶化木葡聚糖制剂。
Int J Pharm. 2001 Oct 23;229(1-2):29-36. doi: 10.1016/s0378-5173(01)00825-0.
10
Sustained release ophthalmic formulations of pilocarpine.毛果芸香碱缓释眼用制剂
J Pharm Pharmacol. 1989 Mar;41(3):197-200. doi: 10.1111/j.2042-7158.1989.tb06430.x.

引用本文的文献

1
Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders.新兴眼部疾病局部给药系统的研究进展。
Curr Drug Res Rev. 2024;16(3):251-267. doi: 10.2174/0125899775266634231213044704.
2
Advances in Nanogels for Topical Drug Delivery in Ocular Diseases.用于眼部疾病局部给药的纳米凝胶研究进展
Gels. 2023 Apr 2;9(4):292. doi: 10.3390/gels9040292.
3
Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system.制备及体外抗菌评价加替沙星黏附性凝胶系统。
Daru. 2010;18(4):237-46.
4
Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance.通过表面等离子体共振分析跨膜眼部粘蛋白与黏附性聚合物和树枝状聚合物的界面相互作用。
Pharm Res. 2012 Aug;29(8):2329-40. doi: 10.1007/s11095-012-0761-1. Epub 2012 May 8.
5
Sodium alginate based mucoadhesive system for gatifloxacin and its in vitro antibacterial activity.基于海藻酸钠的加替沙星粘膜粘附系统及其体外抗菌活性。
Sci Pharm. 2010 Oct-Dec;78(4):941-57. doi: 10.3797/scipharm.1004-24. Epub 2010 Sep 26.